DR. JEAN CHRISTOPHE LAPIERE, M.D.

CHICAGO, IL

Research Active
Dermatology - MOHS-Micrographic Surgery NPI registered 21+ years 1 publication 2019 – 2019 NPI: 1598760977
CTLA-4 AntigenMelanomaAntineoplastic Agents, ImmunologicalAntineoplastic Combined Chemotherapy ProtocolsImmunotherapyKidney NeoplasmsProgrammed Cell Death 1 Receptor

Practice Location

737 N MICHIGAN AVE
CHICAGO, IL 60611-2635

Phone: (312) 266-6647

Publications in plain English

The clinical added value of the addition of anti-CTL-4 to anti-PD-1 alone is questionable and clearly increasing toxicity regarding pivotal studies in the treatment of melanoma and renal carcinoma.

2019

Cancer chemotherapy and pharmacology

Albin N, Monard A, Lapiere J

PubMed

Frequent Co-Authors

Nicolas Albin Adrien Monard

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.